BEQ inquiry from health authority [Study As­sess­ment]

posted by Aymanmy – Jordan, 2019-12-18 09:51 (1147 d 06:01 ago) – Posting: # 20990
Views: 3,609

Hi colleagues
Recently we submitted a BE study to EU, and we recieved an inquiry about in some subjects (5 out of 60) the LLOQ is more than 5% of the Cmax, plz need to know how can we reply about this case since the method was applicable for more than 90% of the subjects in the study and the LLOQ is actually less than 5% of the average Cmax, and no detected concentrations in the predose samples for these subjects.
Kind regards


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
18 visitors (0 registered, 18 guests [including 7 identified bots]).
Forum time: 15:52 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5